The FDA has given Bio-Rad Laboratories clearance for its BioPlex 2200 Syphilis Total & RPR assay, a fully automated Treponemal/non-Treponemal dual test intended for the diagnosis of syphilis infection. The assay allows for simultaneous detection of antibodies to T. pallidum and reagin antibodies and rapid plasma reagin titer determination to facilitate treatment monitoring.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.